Shanghai Serum Bio-Technology Co Ltd banner
S

Shanghai Serum Bio-Technology Co Ltd
SSE:688163

Watchlist Manager
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
Watchlist
Price: 33.99 CNY 3% Market Closed
Market Cap: ¥3.7B

Shanghai Serum Bio-Technology Co Ltd
Investor Relations

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, and sale of anti-toxin and anti-serum products. The company is headquartered in Shanghai, Shanghai and currently employs 308 full-time employees. The company went IPO on 2022-03-11. The firm is mainly engaged in the research, development, manufacturing and sales of preventive and therapeutic drugs in the field of biotoxins and biosafety. The firm's main products include anti-pit viper venom, anti-five-step snake venom, anti-bungi venom, anti-cobra venom, equine immunoglobulin and anti-rabies serum. The firm's products are mainly used for emergency snakebite treatment. The firm mainly conducts its businesses in the domestic market.

Show more
Loading
688163
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Tiejiong Fan
GM & Director
No Bio Available
Mr. Shaoyang Li
Chief Financial Officer
No Bio Available
Ms. Qiong Cheng
Deputy GM & Board Secretary
No Bio Available
Mr. Hao Zhang
General Manager Assistant
No Bio Available
Mr. Liangjun Peng
Deputy General Manager
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
No. 1288, Huaqing Road, Qingpu District
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett